India’s diagnostic technology space in the last few years have seen a surge in innovative solutions that will certainly transform the future of lab diagnosis. Technologies such as AI, machine learning, automation are already disrupting traditional practices and remodeling current lab infrastructure while improving clinical decisions. Addressing the opportunities lying ahead, technology providers are now going that extra mile to develop technologies that suit the needs of the next generation laboratories. Roche Diagnostics India, the company at the forefront of these innovations in July 2019 introduced cobas® pro- its integrated solutions which bring several ‘first-of-its-kind’ features for labs.
The Indian opportunity
According to Roche Diagnostics India, cobas® pro represents Roche’s new generation of Serum Work Area solutions that endeavors to improve the speed and reliability of treatment decisions for patients and their families. This solution promises to offer greater automation, flexibility and simplified workflow to support better clinical outcomes for patients. They are designed to reduce the time between diagnosis and therapy management and to instill greater confidence in clinical decision making. It also includes efficiency-building features like automated maintenance and calibration and an on-the-fly reagents and auxiliary loading mechanism that improves functional efficiencies within laboratories.
When asked about the striking features of this integrated lab solution, Dr. Shravan Subramanyam informs, “A fully integrated laboratory is the means to this end. One in which every component is designed to work together as one, vastly expanding the efficiency, scope, and quality of diagnostic capabilities. Roche Diagnostics had introduced its industry’s first integrated system in 2002 and since then, there has been consistent evolution. cobas® pro takes integration to a different level altogether with its unique features helping labs on the challenges around “turn around time”, limited space, qualified staff dependencies, and assay menu requirement and consolidation. Quite simply, we are enabling within a single automated system, a vast array of testing that gives answers to life’s critical challenges across the healthcare continuum.”
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines
READ THE ENTIRE ISSUE